NEW DELHI: ONGC’s consolidated net profit spiked nearly 78% to Rs 11,527 crore in the fourth quarter of 2023-24 from Rs 6,478 crore in the previous corresponding period on the back of increased crude production and elevated global prices, which also jacked up the annual profit by 68% to Rs 57,101 crore against Rs 34,046 crore in 2022-23. tnn
We also published the following articles recently
Zydus Lifesciences FY 24 net profit jumps 97%
Zydus Lifesciences Limited reported a 97% jump in consolidated net profit to Rs 3,859.5 crore, attributed to strong demand in key US and domestic markets. The company’s shares rallied 4.28% on BSE. Dr Sharvil Patel, managing director, highlighted patient centricity, operational efficiency, and strategic investments as key factors.
Zydus Lifesciences Limited reported a 97% jump in consolidated net profit to Rs 3,859.5 crore, attributed to strong demand in key US and domestic markets. The company’s shares rallied 4.28% on BSE. Dr Sharvil Patel, managing director, highlighted patient centricity, operational efficiency, and strategic investments as key factors.
Medanta net profit up on higher revenue
Global Health, operating Medanta Hospitals, reported a 26% YoY increase in net profit to Rs 127 crore for Q4FY24. The revenue growth was driven by matured and new hospitals, with higher patient volumes. The occupancy rate stood at 59% with stable EBITDA margins at 24.7%. EBITDA rose 8% YoY to Rs 206.
Global Health, operating Medanta Hospitals, reported a 26% YoY increase in net profit to Rs 127 crore for Q4FY24. The revenue growth was driven by matured and new hospitals, with higher patient volumes. The occupancy rate stood at 59% with stable EBITDA margins at 24.7%. EBITDA rose 8% YoY to Rs 206.
